Rem-Fit Partners with TGen in Technology Driven Study
Furniture World News Desk on
2/11/2018
The partnership between REM-Fit and TGen offers ZEEQ Smart Pillow users an easy way to share their anonymous sleep data with the simple click of an opt-in option in the ZEEQ app.
REM-Fit, the Chicago-based sleep technology and bedding company, recently announced a partnership with neuroscientists at the non-profit Translational Genomics Research Institute (TGen) to merge DNA analysis with sleep quantitation driven by data from REM-Fit’s ZEEQ Smart Pillow.
“The ZEEQ Smart Pillow offers a unique opportunity for us to characterize a person’s sleep patterns in a very low impact way. Measuring the parameters of sleep in a person’s own bed and across many months greatly increases our ability to accurately assess that individual’s sleep style,” said Dr. Matt Huentelman, a Professor in TGen’s Neurogenomics division. “Combining this in-depth individual sleep data with information about that same person’s genetic code is an exciting way to efficiently study the factors that may affect sleep in the general population. We are thrilled to have REM-Fit as our first partner in the sleep industry and to offer ZEEQ users the opportunity to seamlessly participate in scientific research that could potentially uncover new information about sleep.”
The partnership between REM-Fit and TGen offers ZEEQ Smart Pillow users an easy way to share their anonymous sleep data with the simple click of an opt-in option in the ZEEQ app. A good night’s sleep is important. Research has shown the average adult requires seven or more hours of sleep to feel rested. Optimal sleep also plays a role in the bodies control of weight, overall physical health, and mental acuity.
The data collected through the app will enable researchers to identify those individuals who sleep less than six hours each night. For less than three percent of the population, known as natural short sleepers, this is normal. For the average adult, however, follow-up DNA analysis would separate the short sleepers from those who simply lack sleep and — hopefully — identify why.
“The science of sleep and relation of genetics to it is a largely unexplored topic and one we feel provides an opportunity for ZEEQ users to advance the science of sleep through a unique, first-of-its-kind collaboration,” said Warrick Bell, Vice President of Product at REM-Fit. “Of course, we are pleased that TGen believes ZEEQ can add value at the research bench as well.”
The ZEEQ Smart Pillow provides sleep-tracking data through both physical and auditory sensors; it enhances sleep through streaming music to built-in speakers, helps eliminate snoring with its integrated Snore Alarm, and connects to other smart devices through connected services like IFTTT and Amazon Alexa. Learn more and order your own ZEEQ at
www.zeeqpillow.com.
More about REM-Fit: REM-Fit is an active lifestyle bedding and technology brand focused on driving the development of sleep technology introduced in 2014. With offerings that include activity and sleep trackers, recovery-enhancing mattresses, high quality bedding and ZEEQ, the world’s first smart pillow, REM-Fit provides full sleep systems designed to improve rest and recovery. For more information, visit www.rem-fit.com.
More about TGen: Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, diabetes, and infectious diseases, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is affiliated with City of Hope, a world-renowned independent research and cancer and diabetes treatment center: www.cityofhope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: www.tgen.org.